# Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

> **NCT00304993** · PHASE4 · COMPLETED · sponsor: **Foundation Research, Florida** · enrollment: 30 (—)

## Conditions studied

- Metabolic Syndrome X
- Insulin Resistance

## Interventions

- **DRUG:** fenofibrate
- **DRUG:** niacin
- **DRUG:** rosiglitazone

## Key facts

- **NCT ID:** NCT00304993
- **Lead sponsor:** Foundation Research, Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304993, "Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00304993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*